Lack of Influence of Serum Magnesium Levels on Overall Mortality and Cardiovascular Outcomes in Patients with Advanced Chronic Kidney Disease

<table>Kaplan-Meier development of fatal and nonfatal cardiovascular events curves according to median serum magnesium levels (&lt;2.1 mg/dL or ≥2.1 mg/dL).</table>

International Scholarly Research Notices

fig2

Figure 2

Figure 2: Lack of Influence of Serum Magnesium Levels on Overall Mortality and Cardiovascular Outcomes in Patients with Advanced Chronic Kidney Disease 

Figure 2 | Lack of Influence of Serum Magnesium Levels on Overall Mortality and Cardiovascular Outcomes in Patients with Advanced Chronic Kidney Disease 